OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Neurology is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Medical technologies, telemedicine and artificial intelligence for neurotrauma and neurorehabilitation	63
Management of neuropsychiatric symptoms in dementia	56
The recent surge of functional movement disorders: social distress or greater awareness?	52
Cortical hyperexcitability in amyotrophic lateral sclerosis: from pathogenesis to diagnosis	49
Update on management of cerebral venous thrombosis	45
Editorial introductions	43
From basic mechanisms to therapeutic perspectives in cluster headache	42
Gene therapies for CMT neuropathies: from the bench to the clinic	41
Primary central nervous system lymphoma: advances in its pathogenesis, molecular markers and targeted therapies	39
Microglia in multiple sclerosis – pathogenesis and imaging	33
Neuro-oncology is moving quickly toward new horizons of diagnosis and treatment	32
Hereditary motor neuropathies	31
Neurology education in the era of artificial intelligence	31
Neurosyphilis in 2025: Erratum	29
Historical development and contemporary use of neuromodulation in human spinal cord injury	29
Central nervous system adverse events of immune checkpoint inhibitors	27
The role of the gut microbiome in Alzheimer's disease pathophysiology	25
The 2021 WHO classification of central nervous system tumors: what neurologists need to know	25
Updates in neuro-otology	24
Editorial introductions	24
Editorial: Epilepsy advances in 2023	23
Connecting tremors – a circuits perspective	23
Multiple sclerosis in China: the current state of diagnosis and management	23
Development of neural repair therapy for chronic spinal cord trauma: soluble Nogo receptor decoy from discovery to clinical trial	22
The pathogenesis of neurologic symptoms of the postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection	22

New chronic inflammatory demyelinating polyneuropathy/Guillain–Barré syndrome guidelines – impact on clinical practise	22
Burning vertex syndrome: a novel unclassified headache - its preliminary observations, and possible mechanisms	21
Threat of resurgence or hope for global eradication of poliovirus?	21
COVID-19 related headaches: epidemiology, pathophysiology, impacts, and management	21
Migraine in women: a review	20
Revascularization of arterial occlusions in posterior circulation acute ischemic stroke	20
The FSHD jigsaw: are we placing the tiles in the right position?	20
Thymectomy in myasthenia gravis	20
Levodopa infusion therapies for Parkinson disease	20
Interest of rare autoantibodies in autoimmune encephalitis and paraneoplastic neurological syndromes: the utility (or futility) of rare antibody discovery	19
Tuberculosis of the central nervous system: current concepts in diagnosis and treatment	19
Update on the clinical and therapeutic aspects of myotonic dystrophy type 1	19
Nerve ultrasound in the diagnosis of inflammatory neuropathies	19
fMRI-based spatio-temporal parcellations of the human brain	18
Idiopathic intracranial hypertension: expanding our understanding	18
Red flags in multiple sclerosis	18
Clinical impact of molecular profiling in rare brain tumors	18
Update on dermatomyositis	18
Electrical stimulation of the peripheral and central vestibular system	18
Diet and migraine: what is proven?	17
Gauging and controlling excitability in cortical disorders	17
Acute stroke care in low and middle-income countries	17
MRI for the diagnosis of limb girdle muscular dystrophies	17
Editorial: The gap between academic advances and therapy development in motor neuron disease	16
Obesity-related neuropathy: the new epidemic	16
Neurosyphilis in 2025	16
New developments in diagnostics and treatment of adult-onset focal dystonia	16
Novel approaches to treatment of leptomeningeal metastases	16
Parkinson's disease – genetic cause	16
Targeting IDH1/IDH2 mutations in gliomas	15
Recent advances in Alzheimer disease genetics	15
Progress in spinal muscular atrophy research	15
Susceptibility and disease modifier genes in amyotrophic lateral sclerosis: from genetic associations to therapeutic implications	15
Choroid plexuses at the interface of peripheral immunity and tissue repair in multiple sclerosis	15
Clinical trials in dementia with Lewy bodies: the evolving concept of co-pathologies, patient selection and biomarkers	15
Towards multimodal cognition-based treatment for cognitive impairment in Parkinson's disease: drugs, exercise, non-invasive brain stimulation and technologies	15
Optic neuritis: current challenges in diagnosis and management	15
Neuroinflammation and immunometabolism in neurodegenerative diseases	15
Coronavirus disease 2019 infection and cerebrovascular diseases: an update on the pathophysiology and management	14
Diagnosing viral encephalitis and emerging concepts	14
Fluid phase biomarkers in multiple sclerosis	14
Sex and gender differences in neurological infections	14
Monitoring multiple sclerosis: digital and fluid phase biomarkers	14
Recent insights in striated muscle laminopathies	13
Current trend in air pollution exposure and stroke	13
Update on genetics of amyotrophic lateral sclerosis	13
New insights in the immune treatment of Guillain–Barré syndrome	13
Current opinion: Racial and ethnic health disparities in multiple sclerosis: considering the social determinants of health	13
Chronic idiopathic axonal neuropathy: antibodies, genetics, and beyond	13
Abnormal energy metabolism in ALS: a key player?	13

Vestibular migraine. Clinical and diagnostic challenges, and emerging therapeutic approaches	12
Editorial: Making the invisible visible: updates on vestibular neurology	12
Challenges in studying disparities in neuropsychiatric hyperkinetic movement disorders	12
Imaging of vestibular function and disorders and its clinical relevance	12
Precision medicine in Moyamoya vasculopathy	12
Neurocognitive and psychiatric post-coronavirus disease 2019 conditions: pathogenic insights of brain dysfunction following severe acute respiratory syndrome coronavirus 2 infection	12
Recent advances in portable, low-field magnetic resonance imaging in cerebrovascular disease	12
Editorial introductions	12
Clinical and neuroimaging features of the progressive supranuclear palsy- corticobasal degeneration continuum	12
The state of art on the use of patient reported outcomes in migraine	12
In-vivo diagnosis of cerebral amyloid angiopathy: an updated review	11
Peripheral visual field loss and activities of daily living	11
Myofibrillar myopathy: towards a mechanism-based definition as a Z-disk-opathy	11
Therapeutic thoroughfares for adults living with Pompe disease	11
Progress in treatment of gliomas	11
Editorial: Seizure disorders: 2023 update	11
Imaging cortical lesions in multiple sclerosis	11
Current gaps in acute reperfusion therapies	11
New and emerging pharmacologic treatments for developmental and epileptic encephalopathies	11
Mechanisms of coronavirus infectious disease 2019-related neurologic diseases	11
Muscle ultrasound in myopathies	11
Update on modifiable risk factors for Alzheimer's disease and related dementias	11
Long COVID and especially headache syndromes	11
Life after autoantibody-mediated encephalitis: optimizing follow-up and management in recovering patients	11
Immune checkpoint inhibitors induced side effects of the peripheral nervous system	11
Nonneurologic causes of binocular diplopia for the neurologist	11